data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Neurocrine Biosciences
(NASDAQ:NBIX)
$99.25
1.77[1.82%]
At close: Jul 1
$99.25
00
After Hours: 4:36PM EDT
Day High/Low97.5 - 99.39
52 Week High/Low71.88 - 108.02
Open / Close97.5 / 99.25
Float / Outstanding83.1M / 95.6M
Vol / Avg.655.9K / 763.3K
Mkt Cap9.5B
P/E135.96
50d Avg. Price90.83
Div / Yield-
Payout Ratio-
EPS0.15
Total Float83.1M

Neurocrine Biosciences (NASDAQ:NBIX), Quotes and News Summary

Neurocrine Biosciences (NASDAQ: NBIX)

Day High/Low97.5 - 99.39
52 Week High/Low71.88 - 108.02
Open / Close97.5 / 99.25
Float / Outstanding83.1M / 95.6M
Vol / Avg.655.9K / 763.3K
Mkt Cap9.5B
P/E135.96
50d Avg. Price90.83
Div / Yield-
Payout Ratio-
EPS0.15
Total Float83.1M
Benzinga - Sponsored
Benzinga - Jun 13, 2022, 8:05AM
Benzinga - Jun 6, 2022, 9:49AM
Benzinga - May 23, 2022, 8:34AM
Benzinga - May 10, 2022, 9:39AM
Benzinga - May 4, 2022, 7:40AM
Benzinga - Apr 12, 2022, 9:03AM
Benzinga - Apr 4, 2022, 9:41AM
Benzinga - Mar 28, 2022, 4:37PM
Benzinga - Mar 3, 2022, 6:17AM
Benzinga - Feb 25, 2022, 5:03AM
Benzinga - Feb 14, 2022, 8:19AM
Benzinga - Feb 11, 2022, 11:53AM
Benzinga - Feb 11, 2022, 11:44AM
Benzinga - Feb 11, 2022, 7:35AM
Benzinga - Feb 11, 2022, 7:34AM
Benzinga - Feb 1, 2022, 9:07AM
Benzinga - Jan 20, 2022, 9:55AM
load more
Sector: Health Care.Industry: Biotechnology
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-02
REV
Q1 2022Est.ActualSurprise
EPS0.3400.300 -0.0400
REV303.400M310.600M7.200M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Neurocrine Biosciences Questions & Answers

Q
How do I buy Neurocrine Biosciences (NBIX) stock?
A

You can purchase shares of Neurocrine Biosciences (NASDAQ: NBIX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Neurocrine Biosciences's (NBIX) competitors?
Q
What is the target price for Neurocrine Biosciences (NBIX) stock?
A

The latest price target for Neurocrine Biosciences (NASDAQ: NBIX) was reported by Jefferies on Monday, June 6, 2022. The analyst firm set a price target for 112.00 expecting NBIX to rise to within 12 months (a possible 12.85% upside). 20 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Neurocrine Biosciences (NBIX)?
A

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $99.25 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Neurocrine Biosciences (NBIX) pay a dividend?
A

There are no upcoming dividends for Neurocrine Biosciences.

Q
When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?
A

Neurocrine Biosciences’s Q2 earnings are confirmed for Tuesday, August 2, 2022.

Q
Is Neurocrine Biosciences (NBIX) going to split?
A

There is no upcoming split for Neurocrine Biosciences.

Q
What sector and industry does Neurocrine Biosciences (NBIX) operate in?
A

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.